IL6 and tuberculosis: As in the case of sepsis, community-acquired pneumonia and TB [35–37], hypolipidemia in patients with COVID-19 has been associated with increased disease severity, and inflammatory markers, such as C-reactive protein and IL-6 were inversely correlated with serum total cholesterol and low-density lipoprotein (LDL) levels [38].